中工國際(002051.SZ):與關聯方組成聯合體簽署5532萬元經營合同
格隆匯6月19日丨中工國際(002051.SZ)公佈,近日,公司下屬全資公司京興國際工程管理有限公司收到廊坊市第四人民醫院新建項目全過程工程諮詢合同。京興國際、中國中元國際工程有限公司和關聯方機械工業勘察設計研究院有限公司組成的聯合體與廊坊市第四人民醫院簽署了廊坊市第四人民醫院新建項目全過程工程諮詢合同。
廊坊市第四人民醫院新建項目全過程工程諮詢合同金額為5,532萬元,其中項目建設管理服務、工程設計及工程監理等費用5,174萬元,工程勘察費358萬元。該項目位於河北省霸州市。項目內容為項目建設管理服務、工程勘察、工程設計、工程監理、造價諮詢、招標代理、其他專項評價諮詢。
廊坊市第四人民醫院新建項目全過程工程諮詢合同金額為5,532萬元,公司下屬全資公司所佔份額為5,174萬元,為公司2022年營業總收入971,723.86萬元的0.53%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.